Plain-English translation of NCT06100718 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The INVISIBLE-1 study is investigating whether patients who have had an ischemic stroke (a type of stroke caused by a blood clot) and have certain blood markers might have an undiagnosed cancer that was missed at the time of their stroke. Researchers want to understand how often hidden cancers are discovered in this group of patients over the year following their stroke.
Some strokes happen because of hidden cancers that create blood clots in unusual ways. Current estimates suggest about 10% of stroke patients in this high-risk group are later found to have cancer, but researchers believe this number may actually be higher. This study aims to get a better picture of how often this happens and what happens to these cancers over time.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be enrolled shortly after your stroke while you are in the hospital. Your main participation involves receiving a phone call one year after your stroke to answer questions about your health and whether you have been diagnosed with any new cancers during that year. The researchers will also review your medical records to confirm information about any cancers found. There are no medications or procedures to undergo as part of the study itself.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Switzerland